What are the challenges and side effects associated with Imetelstat?
Despite its potential, imetelstat is not without challenges. Some patients experience adverse effects, including hematological toxicity, which can manifest as thrombocytopenia, neutropenia, and anemia. These side effects necessitate careful monitoring and dose adjustments. Furthermore, the development of resistance and variability in patient response highlight the need for further research to optimize treatment protocols and identify biomarkers for response prediction.
